IQGAP3 May Serve as a Promising Biomarker in Clear Cell Renal Cell Carcinoma

References

• Grignon DJ, Che M. Clear cell renal cell carcinoma. Clin Lab Med. 2005;25(2):305–316. doi:10.1016/j.cll.2005.01.012
   PubMed Web of Science ®Google Scholar
• Hsieh JJ, Purdue MP, Signoretti S, et al. Renal cell carcinoma. Nat Rev Dis Primers. 2017;3:17009. doi:10.1038/nrdp.2017.9
   PubMed Web of Science ®Google Scholar
• Escudier B, Porta C, Schmidinger M, et al. Renal cell carcinoma: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2016;27(suppl 5):v58–v68. doi:10.1093/annonc/mdw328
   PubMed Web of Science ®Google Scholar
• Barata PC, Rini BI. Treatment of renal cell carcinoma: current status and future directions. CA Cancer J Clin. 2017;67(6):507–524. doi:10.3322/caac.21411
   PubMed Web of Science ®Google Scholar
• Shi Y, Qin N, Zhou Q, et al. Role of IQGAP3 in metastasis and epithelial-mesenchymal transition in human hepatocellular carcinoma. J Transl Med. 2017;15(1):176. doi:10.1186/s12967-017-1275-8
   PubMed Web of Science ®Google Scholar
• Fang X, Zhang B, Thisse B, Bloom GS, Thisse C. IQGAP3 is essential for cell proliferation and motility during zebrafish embryonic development. Cytoskeleton. 2015;72(8):422–433. doi:10.1002/cm.21237
   PubMed Web of Science ®Google Scholar
• Jinawath N, Shiao MS, Chanpanitkitchote P, Svasti J. Enhancement of migration and invasion of gastric cancer cells by IQGAP3. Biomolecules. 2020;10(8):1194.
   PubMed Web of Science ®Google Scholar
• Zeng Y, Jie X, Wu B, Wu G, Liu L, Xu S. IQGAP3 interacts with Rad17 to recruit the Mre11-Rad50-Nbs1 complex and contributes to radioresistance in lung cancer. Cancer Lett. 2020;493:254–265. doi:10.1016/j.canlet.2020.08.042
   PubMed Web of Science ®Google Scholar
• Xu W, Xu B, Yao Y, et al. Overexpression and biological function of IQGAP3 in human pancreatic cancer. Am J Transl Res. 2016;8(12):5421–5432.
   PubMed Web of Science ®Google Scholar
• Hutter C, Zenklusen JC. The cancer genome atlas: creating lasting value beyond its data. Cell. 2018;173(2):283–285. doi:10.1016/j.cell.2018.03.042
   PubMed Web of Science ®Google Scholar
• Zhang J, Bajari R, Andric D. The international cancer genome consortium data portal. Nat Biotechnol. 2019;37(4):367–369. doi:10.1038/s41587-019-0055-9
   PubMed Web of Science ®Google Scholar
• von Roemeling CA, Radisky DC, Marlow LA, et al. Neuronal pentraxin 2 supports clear cell renal cell carcinoma by activating the AMPA-selective glutamate receptor-4. Cancer Res. 2014;74(17):4796–4810. doi:10.1158/0008-5472.CAN-14-0210
   PubMed Web of Science ®Google Scholar
• Peña-Llopis S, Vega-rubín-de-celis S, Liao A, et al. BAP1 loss defines a new class of renal cell carcinoma. Nat Genet. 2012;44(7):751–759. doi:10.1038/ng.2323
   PubMed Web of Science ®Google Scholar
• Peña-Llopis S, Brugarolas J. Simultaneous isolation of high-quality DNA, RNA, miRNA and proteins from tissues for genomic applications. Nat Protoc. 2013;8(11):2240–2255. doi:10.1038/nprot.2013.141
   PubMed Web of Science ®Google Scholar
• Li T, Fan J, Wang B, et al. TIMER: a web server for comprehensive analysis of tumor-infiltrating immune cells. Cancer Res. 2017;77(21):e108–e110. doi:10.1158/0008-5472.CAN-17-0307
   PubMed Web of Science ®Google Scholar
• Chandrashekar DS, Bashel B, Balasubramanya SAH, et al. UALCAN: a portal for facilitating tumor subgroup gene expression and survival analyses. Neoplasia. 2017;19(8):649–658. doi:10.1016/j.neo.2017.05.002
   PubMed Web of Science ®Google Scholar
• Chen F, Chandrashekar DS, Varambally S, Creighton CJ. Pan-cancer molecular subtypes revealed by mass-spectrometry-based proteomic characterization of more than 500 human cancers. Nat Commun. 2019;10(1):1–15.
   PubMed Web of Science ®Google Scholar
• Colwill K, Gräslund S. A roadmap to generate renewable protein binders to the human proteome. Nat Methods. 2011;8(7):551–558. doi:10.1038/nmeth.1607
   PubMed Web of Science ®Google Scholar
• Zhou Y, Zhou B, Pache L, et al. Metascape provides a biologist-oriented resource for the analysis of systems-level datasets. Nat Commun. 2019;10(1):1–10.
   PubMed Web of Science ®Google Scholar
• Newman AM, Liu CL, Green MR. Robust enumeration of cell subsets from tissue expression profiles. Nat Methods. 2015;12(5):453–457. doi:10.1038/nmeth.3337
   PubMed Web of Science ®Google Scholar
• Martincorena I, Raine KM, Gerstung M, et al. Universal patterns of selection in cancer and somatic tissues. Cell. 2017;171(5):1029–1041. doi:10.1016/j.cell.2017.09.042
   PubMed Web of Science ®Google Scholar
• Bortoluzzi S, Coppe A, Bisognin A, Pizzi C, Danieli GA. A multistep bioinformatic approach detects putative regulatory elements in gene promoters. BMC Bioinform. 2005;6:121. doi:10.1186/1471-2105-6-121
   PubMed Web of Science ®Google Scholar
• Gao T, Yu L, Fang Z, et al. KIF18B promotes tumor progression in osteosarcoma by activating β-catenin. Cancer Biol Med. 2020;17(2):371–386. doi:10.20892/j.issn.2095-3941.2019.0452
   PubMed Web of Science ®Google Scholar
• Yang B, Wang S, Xie H, et al. KIF18B promotes hepatocellular carcinoma progression through activating Wnt/β-catenin-signaling pathway. J Cell Physiol. 2020;235(10):6507–6514. doi:10.1002/jcp.29444
   PubMed Web of Science ®Google Scholar
• Yang H, Wang Y, Zhang Z, Li H. Identification of KIF18B as a hub candidate gene in the metastasis of clear cell renal cell carcinoma by weighted gene co-expression network analysis. Front Genet. 2020;11:905. doi:10.3389/fgene.2020.00905
   PubMed Web of Science ®Google Scholar
• Pan D, Walstein K, Take A, et al. Mechanism of centromere recruitment of the CENP-A chaperone HJURP and its implications for centromere licensing. Nat Commun. 2019;10(1):1–18.
   PubMed Web of Science ®Google Scholar
• Chen T, Huang H, Zhou Y, et al. HJURP promotes hepatocellular carcinoma proliferation by destabilizing p21 via the MAPK/ERK1/2 and AKT/GSK3β signaling pathways. J Exp Clin Cancer Res. 2018;37(1):193. doi:10.1186/s13046-018-0866-4
   PubMed Web of Science ®Google Scholar
• Li L, Wei JR, Song Y, et al. TROAP switches DYRK1 activity to drive hepatocellular carcinoma progression. Cell Death Dis. 2021;12(1):125.
   PubMed Web of Science ®Google Scholar
• Kastan MB, Bartek J. Cell-cycle checkpoints and cancer. Nature. 2004;432(7015):316–323. doi:10.1038/nature03097
   PubMed Web of Science ®Google Scholar
• Sancar A, Lindsey-Boltz LA, Unsal-Kaçmaz K, Linn S. Molecular mechanisms of mammalian DNA repair and the DNA damage checkpoints. Annu Rev Biochem. 2004;73:39–85. doi:10.1146/annurev.biochem.73.011303.073723
   PubMed Web of Science ®Google Scholar
• Cortez D. Replication-coupled DNA repair. Mol Cell. 2019;74(5):866–876. doi:10.1016/j.molcel.2019.04.027
   PubMed Web of Science ®Google Scholar
• Gajewski TF, Schreiber H, Fu YX. Innate and adaptive immune cells in the tumor microenvironment. Nat Immunol. 2013;14(10):1014–1022. doi:10.1038/ni.2703
   PubMed Web of Science ®Google Scholar
• Takeuchi Y, Nishikawa H. Roles of regulatory T cells in cancer immunity. Int Immunol. 2016;28(8):401–409. doi:10.1093/intimm/dxw025
   PubMed Web of Science ®Google Scholar
• Kurahara H, Takao S, Maemura K, et al. M2-polarized tumor-associated macrophage infiltration of regional lymph nodes is associated with nodal lymphangiogenesis and occult nodal involvement in pN0 pancreatic cancer. Pancreas. 2013;42(1):155–159. doi:10.1097/MPA.0b013e318254f2d1
   PubMed Web of Science ®Google Scholar
• Topalian SL, Taube JM, Anders RA, Pardoll DM. Mechanism-driven biomarkers to guide immune checkpoint blockade in cancer therapy. Nat Rev Cancer. 2016;16(5):275–287. doi:10.1038/nrc.2016.36
   PubMed Web of Science ®Google Scholar
• Paré L, Pascual T, Seguí E, et al. Association between PD1 mRNA and response to anti-PD1 monotherapy across multiple cancer types. Ann Oncol. 2018;29(10):2121–2128. doi:10.1093/annonc/mdy335
   PubMed Web of Science ®Google Scholar
• Rowshanravan B, Halliday N. CTLA-4: a moving target in immunotherapy. Blood J Am Soc Hematol. 2018;131(1):58–67.
   Google Scholar
• Lichtenegger FS, Rothe M, Schnorfeil FM, et al. Targeting LAG-3 and PD-1 to enhance T cell activation by antigen-presenting cells. Front Immunol. 2018;9:385. doi:10.3389/fimmu.2018.00385
   PubMed Web of Science ®Google Scholar
• Anderson AC, Joller N, Kuchroo VK. Lag-3, Tim-3, and TIGIT: co-inhibitory receptors with specialized functions in immune regulation. Immunity. 2016;44(5):989–1004. doi:10.1016/j.immuni.2016.05.001
   PubMed Web of Science ®Google Scholar